BackgroundCheck.run
Search For

Michael Mason Riggs, 54Santa Rita, AZ

Known as:
Michael M Riggs
Related to:
Jenny S Weil Leonard R Baker 90 Micaela R Riggs 36 Jane Riggs John S Riggs Mary C Muller Thomas A Brinson 44 Mary C Riggs

Michael Riggs Phones & Addresses

Vail, AZ   

Green Valley, AZ   

1434 W Kandy Ct, Tucson, AZ 85745   

Pearce, AZ   

Get Report
Control this profile

Mentions for Michael Mason Riggs

Career records & work history

Medicine Doctors

Michael O. Riggs

Specialties:
General Surgery, Vascular Surgery
Work:
Michael O Riggs MD
13901 Mcauley Blvd STE 210, Oklahoma City, OK 73134
405-6088828 (phone) 405-6081914 (fax)
Education:
Medical School
University of Oklahoma College of Medicine at Oklahoma City
Graduated: 1983
Procedures:
Abdominal Aortic Aneurysm, Arthrocentesis, Endoscopic Retrograde Cholangiopancreatography (ERCP), Hallux Valgus Repair, Laparoscopic Appendectomy, Laparoscopic Gallbladder Removal, Mastectomy, Proctosigmoidoscopy, Small Bowel Resection, Spleen Surgey, Thyroid Gland Removal, Gallbladder Removal, Hernia Repair, Tracheostomy, Upper Gastrointestinal Endoscopy
Conditions:
Abdominal Hernia, Appendicitis, Breast Disorders, Cholelethiasis or Cholecystitis, Inguinal Hernia, Malignant Neoplasm of Female Breast, Ventral Hernia
Languages:
English
Description:
Dr. Riggs graduated from the University of Oklahoma College of Medicine at Oklahoma City in 1983. He works in Oklahoma City, OK and specializes in General Surgery and Vascular Surgery. Dr. Riggs is affiliated with Integris Baptist Medical Center and Mercy Hospital Oklahoma City.
Michael Riggs Photo 1

Michael Gwynn Riggs

Specialties:
Allergy & Immunology
Allergy
Internal Medicine
Education:
The University of Texas at Galveston (1972)

License Records

Michael P Riggs

Licenses:
License #: 29484 - Expired
Category: Tow Truck Operator (Consent Tow)
Expiration Date: Nov 26, 2015

Michael Riggs resumes & CV records

Resumes

Michael Riggs Photo 45

Construction

Industry:
Construction
Work:
State Bank of India
Construction
Michael Riggs Photo 46

Senior Technical Writer

Location:
3737 Rock Quarry Rd, Dallas, TX 75211
Industry:
Aviation & Aerospace
Work:
Dayton T. Brown, Inc.
Senior Technical Writer Bombardier Jan 2000 - Dec 2017
Senior Technical Writer - Aircraft Maintenance Engineering
Education:
Embry - Riddle Aeronautical University 1975 - 1979
Bachelors
Skills:
Aerospace, Avionics, Aviation, Aircraft Maintenance, Desktop Publishing, Customer Engagement, Staff Supervision, Project Management, Technical Support, Aerospace Industries, Aeronautics, Federal Government, Civil Aviation, Framemaker, Project Engineering, Airworthiness Certification, Technology Transfer, Document Management, Document Review, Customer Relations, Long Term Customer Relationships, Customer Satisfaction, Mechanical Engineering, Agribusiness, Faa Certifications, Aviation History, Adobe Acrobat
Michael Riggs Photo 47

Michael Riggs

Michael Riggs Photo 48

Michael Riggs

Michael Riggs Photo 49

Michael Riggs

Michael Riggs Photo 50

Michael Riggs

Michael Riggs Photo 51

Michael Riggs

Michael Riggs Photo 52

Michael Riggs

Publications & IP owners

Us Patents

Anti-Cryptosporidium Parvum Preparations

US Patent:
6682737, Jan 27, 2004
Filed:
Apr 25, 2000
Appl. No.:
09/557324
Inventors:
Michael W. Riggs - Tucson AZ
Lance E. Perryman - Cary NC
Assignee:
North Carolina State University - Raleigh NC
International Classification:
A61K 39395
US Classification:
4241511, 4241571, 424535, 424807, 435 722, 435 7021, 435329, 435342, 5303886, 5303891, 530822, 530832
Abstract:
Compositions and methods useful for conferring passive or active immunity to the parasite,. A high molecular weight glycoprotein antigen isolated from , capable of binding the mAb 3E2, was shown to harbor an epitope critical for triggering the neutralizing CSP-like reaction in the parasite. Antibodies targeted against the critical epitope were shown to possess neutralizing activity, and could be combined with other anti- monoclonal antibodies and administered to an animal to confer passive immunity. Immunogenic compositions including the purified antigen are disclosed for use in stimulating an active immune response against.

Anti-Cryptosporidium Parvum Preparations

US Patent:
6730307, May 4, 2004
Filed:
Apr 12, 2001
Appl. No.:
09/832888
Inventors:
Michael W. Riggs - Tucson AZ
Lance E. Perryman - Cary NC
Assignee:
The Arizona Board of Regents Acting on Behalf of the University of Arizona - Tucson AZ
North Carolina State University - Raleigh NC
International Classification:
A61K 39012
US Classification:
4242661, 4241841, 4242651, 4241511, 4242691, 424535, 424807, 435 722, 435329, 435342, 435947, 530350, 5303886, 5303891, 530395, 530822, 530832
Abstract:
Compositions and methods useful for conferring passive or active immunity to the parasite,. A high molecular weight glycoprotein antigen isolated from , capable of binding the mAb 3E2, was shown to harbor an epitope critical for triggering the neutralizing CSP-like reaction in the parasite. Antibodies targeted against the critical epitope were shown to possess neutralizing activity, and could be combined with other anti- monoclonal antibodies and administered to an animal to confer passive immunity. Immunogenic compositions including the purified antigen are disclosed for use in stimulating an active immune response against.

Neutralization-Sensitive Epitopes Of Cryptosporidium Parvum

US Patent:
6759048, Jul 6, 2004
Filed:
Sep 6, 2001
Appl. No.:
09/949186
Inventors:
Lance E. Perryman - Cary NC
Douglas P. Jasmer - Albion WA
Michael W. Riggs - Tucson AZ
Travis C. McGuire - Pullman WA
Assignee:
North Carolina State University - Raleigh NC
Arizona Board of Regents - Tucson AZ
Washington State University Regents - Pullman WA
International Classification:
A61K 3900
US Classification:
4241851, 4241911, 4242651, 4242661, 530300, 530324, 530329, 530350
Abstract:
DNA sequences encoding epitopes to which sporozoite-neutralizing antibodies are directed are provided. Recombinant proteins and synthetic peptides containing epitopes for inducing an antigenic response are described.

Biocides

US Patent:
7566447, Jul 28, 2009
Filed:
Oct 20, 2005
Appl. No.:
11/254500
Inventors:
Jane Homan - Hillpoint WI, US
Michael Imboden - Madison WI, US
Michael Riggs - Tucson AZ, US
Stephane Carryn - Brussels, BE
Deborah A. Schaefer - Tuscon AZ, US
Assignee:
Iogenetics, LLC - Madison WI
The Arizona Board of Regents on Behalf of the University of Arizona - Tucson AZ
International Classification:
A61K 38/43
A61L 9/01
C07K 14/00
C07K 17/00
C07K 1/00
C12P 21/08
C07K 16/00
C11D 3/386
C12S 11/00
US Classification:
424 941, 424 768, 530350, 5303886, 930240, 510305
Abstract:
The present invention relates to the use of biocide (e. g. , bactericidal enzyme) to target pathogens. In particular, the present invention provides biocides for use in health care (e. g. , human and veterinary), agriculture (e. g. , animal and plant production), and food processing (e. g. , water purification).

Targeted Cryptosporidium Biocides

US Patent:
8394379, Mar 12, 2013
Filed:
Jan 13, 2010
Appl. No.:
12/686879
Inventors:
Michael Imboden - Madison WI, US
Michael Warren Riggs - Tucson AZ, US
Deborah A. Schaefer - Tucson AZ, US
Jane Homan - Hillpoint WI, US
Assignee:
ioGenetics, LLC - Madison WI
International Classification:
A61K 39/00
A61K 39/395
US Classification:
4241341, 4241331, 4241411, 4241511
Abstract:
The present invention relates to fusion proteins comprising a microorganism targeting molecule (e. g. , immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.

Targeted Biocides

US Patent:
2007010, May 10, 2007
Filed:
Oct 10, 2006
Appl. No.:
11/545601
Inventors:
Michael Imboden - Madison WI, US
Michael Riggs - Tuscon AZ, US
Deborah Schaefer - Tuscon AZ, US
Assignee:
ioGenetics - Madison WI
University of Arizona - Tucson AZ
International Classification:
A61K 39/40
C07K 16/12
US Classification:
424164100, 530388400
Abstract:
The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzyme) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing). The present invention also relates to methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in various diagnostic applications in number of diverse fields such as agriculture, medicine, and national defense.

Biocides

US Patent:
2008027, Nov 6, 2008
Filed:
Oct 19, 2005
Appl. No.:
11/665950
Inventors:
Jane Homan - Hillpoint WI, US
Michael Imboden - Madison WI, US
Michael W. Riggs - Tucson AZ, US
Stephane Carryn - Zaventen, BE
International Classification:
A61K 38/43
A61K 38/16
A61K 38/46
A61P 33/02
A01N 63/00
A01N 37/18
A01P 15/00
US Classification:
424 946, 514 12, 424 941
Abstract:
The present invention relates to the use of biocide (e.g., bactericidal enzyme) to target pathogens. In particular, the present invention provides biocides for use in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., water purification).

Targeted Biocides

US Patent:
2010003, Feb 11, 2010
Filed:
Aug 5, 2009
Appl. No.:
12/536291
Inventors:
Michael Imboden - Madison WI, US
Michael Riggs - Tucson AZ, US
Deborah A. Schaefer - Tuscon AZ, US
Assignee:
IOGENETICS, LLC - Madison WI
THE ARIZONA BOARD OF REGENTS - Tucson AZ
International Classification:
A61K 39/395
A61P 33/02
A61P 37/04
US Classification:
4241391, 4241511, 4241781
Abstract:
The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzyme) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing). The present invention also relates to methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in various diagnostic applications in number of diverse fields such as agriculture, medicine, and national defense.

Possible Relatives

Cynthia L Riggs  David R Riggs  Dale G Riggs  Dalton K Riggs  Damian Riggs  Dan Riggs  Debra R Riggs  Michael C Last  Michael C Johnson  Michael F Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.